Detected ·
TippingPoint Biosciences
——
TippingPoint Biosciences (CDL'25) closed an oversubscribed $4.5M seed round to advance a breakthrough drug discovery platform targeting epigenetic protein interfaces for undruggable targets, initially focusing on DIPG, an aggressive pediatric brainstem cancer.
- Website
- tippingpointbiosciences.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-04-20 21:07:13 UTC
- Signal ID
- ce539482-7142-47a8-bf2e-3fc3c5429bc1
As the API returns it
{
"id": "ce539482-7142-47a8-bf2e-3fc3c5429bc1",
"created_at": "2026-04-20T21:07:13.441911Z",
"company_name": "TippingPoint Biosciences",
"company_website_url": "tippingpointbiosciences.com",
"company_linkedin_url": "https://www.linkedin.com/company/tippingpoint-biosciences",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*TippingPoint Biosciences (CDL'25) closed an oversubscribed $4.5M seed round to advance a breakthrough drug discovery platform targeting epigenetic protein interfaces for undruggable targets, initially focusing on DIPG, an aggressive pediatric brainstem cancer.*"
}